![]() |
市場調查報告書
商品編碼
1295403
氨基磺酸市場—2023年至2028年預測Sulfamic Acid Market - Forecasts from 2023 to 2028 |
全球氨基磺酸市場預計將從2021年的272,593,000美元增至2028年的424,462,000美元,複合年增長率為5.93%。 氨基磺酸是一種用途廣泛的化合物,用於多種行業,包括清潔劑、水處理、染料和顏料、製藥和工業應用。 化學式為H3NSO3的元素是氨基磺酸。 除了這些名稱之外,它有時也被稱為氨基磺酸、氨基磺酸、氨基硫酸、氨基磺酸等。
快速的工業化、城市化和基礎設施開發項目對氨基磺酸的各種應用產生了巨大的需求,包括除垢劑、金屬清潔和藥品製造。 氨基磺酸市場份額增加的主要原因是各種工業應用的高需求以及個人護理產品的行業需求不斷增長。 個人護理品市場預計將提振氨基磺酸市場。 例如,一家名為 Vishnupriya Chemicals 的獲得 ISO 認證的印度公司定期生產工業級氨基磺酸來替代用於穩定氯的腐蝕抑製劑。
越來越多的政府法規規範氨基磺酸的使用預計將推動市場增長。 例如,歐洲化學品管理局 (ECHA) 根據化學品註冊、評估、授權和限制 (REACH) 法規將氨基磺酸歸類為危險物質。 預計這將導致許多最終用途行業對氨基磺酸的使用進行更嚴格的監管,從而增加對環保型氨基磺酸的需求。
此外,氨基磺酸的生產、使用和處置均受到中國環境保護部的監管和監控。 日本經濟產業省制定了有關氨基磺酸的生產、使用和處置的各種指南,以保護公共安全並促進環境保護。
在造紙和紙漿工業中,氨基磺酸用作漂白劑和紙漿脫木素劑。 由於新興國家對紙張和紙製品的需求增加,氨基磺酸的銷量預計將增加。 不斷增長的數字化趨勢增加了對紙質包裝的需求,並增加了紙張和紙漿行業對氨基磺酸的需求。
氨基磺酸有多種用途,因此在製藥行業備受關注。 氨基磺酸是生產多種藥物分子的原料,例如抗病毒藥物和抗癌藥物。 氨基磺酸作為藥物遞送方法的潛力也正在被研究,該方法可以控制和靶向釋放藥物活性成分。 此外,所有類型的治療藥物,包括抗生素、核甘/核甘酸HIV蛋白□抑製劑(PI)、類固醇硫酸酯□和碳酸酐□抑製劑、抗癲癇藥物和HIV逆轉錄□抑製劑,都使用氨基磺酸鹽。
此外,動物也需要護理和保護以預防各種疾病,隨著農民和動物數量的增加,需要獸藥。 最近,泰國動物補充劑和製藥有限公司推出了OXIPRO,這是一種利用氨基磺酸來保護牲畜免受細菌、真菌和各種其他生物侵害的消毒劑。
按地區看全球氨基磺酸市場,分為北美、南美、歐洲、中東/非洲、亞太地區。 成熟的食品和飲料行業以及 Amino 的新產品推出正在推動該地區的市場增長。 按國家/地區劃分,亞太地區氨基磺酸市場分為中國、印度、日本、韓國、印度尼西亞、泰國、台灣等,其中中國預計將佔據主要市場份額。
隨著中國製造業基礎設施的發展,新興國家已成為含有氨基磺酸的化工產品的主要生產國,預計中國的氨基磺酸市場將大幅增長。 全國大大小小的氨基磺酸生產企業眾多,產能顯著增加。
此外,中國在生產成本和勞動力成本方面具有成本優勢。 低成本的原材料、高效的生產工藝和具有競爭力的勞動力成本使中國成為氨基磺酸生產的具有成本效益的地點。 這一優勢吸引了國內外企業在中國設立生產設施。
The global sulfamic acid market is estimated to grow at a CAGR of 5.93% to reach US$424.462 million in 2028 from US$272.593 million in 2021.Sulfamic acid is a versatile chemical compound used in various industries such as cleaning agents, water treatment, dyes and pigments, pharmaceuticals, and industrial applications. An element having the chemical formula H3NSO3 is sulfamic acid. Along with these names, it is sometimes referred to as amino sulfonic acid, amino sulfonic acid, amido sulfuric acid, and sulfamidic acid.
Rapid industrialization, urbanization, and infrastructure development projects have created a substantial need for sulfamic acid in various applications, such as descaling agents, metal cleaning, and pharmaceutical production. High demand for various industrial applications and a rise in the industry's need for personal care goods are the primary reasons behind the expansion of the sulfamic acid market share. The market for personal care products is anticipated to fuel the sulfamic acid market. For instance, an Indian business with ISO certification called Vishnupriya Chemicals regularly produces technical-grade sulfamic acid to replace the corrosion inhibitors used for chlorine stabilization.
It is anticipated that the extension of government regulations controlling the use of sulfamic acid would support market revenue growth. For instance, the European Chemicals Agency (ECHA) has classified sulfamic acid as hazardous under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) rule. This has led to stricter regulations governing the use of sulfamic acid in many end-use industries, and it is anticipated that these regulations will lead to higher demand for environmentally friendly sulfamic acid.
Additionally, sulfamic acid manufacturing, usage, and disposal have all been subject to regulation and oversight by China's Ministry of Environmental Protection. To safeguard public safety and advance environmental preservation, Japan's Ministry of Economy, Trade, and Industry has created a variety of guidelines for the production, use, and disposal of sulfamic acid.
The paper and pulp industry uses sulfamic acid as a bleaching and pulp delignification chemical. Sulfamic acid sales are predicted to increase due to the increased demand for paper and paper products in emerging nations. The expanding digitalization trend has raised the demand for paper-based packaging, boosting the need for sulfamic acid in the paper and pulp sectors.
Due to its several uses, sulphamic acid has attracted interest in the pharmaceutical sector. In the manufacture of several pharmaceutical molecules, such as antiviral and anticancer medications, it serves as a raw material. Sulphamic acid has also been investigated for its potential as a medication delivery method allowing the regulated and targeted release of medicinally active components. Additionally, antibiotics, nucleoside/nucleotide HIV protease inhibitors (PIs), steroid sulfatase and carbonic anhydrase inhibitors, anti-epileptic medications, HIV reverse transcriptase inhibitors, and other types of therapeutic agents have all been created using sulfamates.
Further, animals also need care and protection against various diseases, and with the increasing farm and animal population comes the need for pharmaceuticals for animals. Recently, Animal Supplement & Pharmaceutical Co., Ltd. in Thailand has launched OXIPRO, a disinfectant to protect farm animals from bacteria, fungi, and various other organisms using sulfamic acid.
The global sulfamic acid market by geography is segmented into North America, South America, Europe, Middle East and Africa, and Asia Pacific. The well-established food & beverage sector and new product launches of amino are driving the regional market growth. By country, the Asia Pacific global sulfamic acid market is divided into China, India, Japan, South Korea, Indonesia, Thailand, Taiwan, and others, where China is anticipated to account for a major market share.
The sulfamic acid market is expected to grow significantly in China owing to the robust manufacturing infrastructure that China has developed, resulting in the country becoming the leading producer of chemicals, including sulfamic acid. The country has many sulfamic acid manufacturers, both large-scale and small-scale, which has significantly increased production capacity.
Furthermore, China offers a cost advantage in production and labor costs. The availability of low-cost raw materials, efficient production processes, and competitive labor costs have made China a cost-effective destination for sulfamic acid manufacturing. This advantage has attracted domestic and international companies to establish production facilities in China.